Evidence map›Paper›PMID 12212839›Full record

ArticleTransgenic research2002

Conditional over-expression of estrogen receptor alpha in a transgenic mouse model.

Kathleen S Hruska, Maddalena T Tilli, Shuxun Ren, Ion Cotarla, Theresa Kwong, Minglin Li, Joseph D Fondell, Judy A Hewitt, Robert D Koos, Priscilla A Furth and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Overexpression of adipose tissue ERα enhances PVAT anticontractility via NOX4-derived HAmerican journal of physiology. Heart and circulatory physiology · 2025
    Article
  2. Article
  3. Article
  4. Point-activated ESR1Genes & development · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Increased sensitivity of estrogen receptor alpha overexpressing antral follicles to methoxychlor and its metabolites.Toxicological sciences : an official journal of the Society of Toxicology · 2011
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kathleen S HruskaDepartment of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland, Baltimore 21201, USA.
Maddalena T Tilli
Shuxun Ren
Ion Cotarla
Theresa Kwong
Minglin Li
Joseph D Fondell
Judy A Hewitt
Robert D Koos
Priscilla A Furth
Jodi A Flaws
University of Maryland, Baltimore · US

Funding

MECHANISMS REGULATING REVERSAL OF PREMALIGNANCYR01CA089041 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FURTH, PRISCILLA A. · 2001 to 2009
$2.0M
THE PRIMORDIAL FOLLICLE ENDOWMENT, BEL-2 AND BCL-XR01HD038955 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI FLAWS, JODI A · 2000 to 2004
$950k
OVARIAN ANGIOGENESISR01CA045055 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI KOOS, ROBERT D · 1986 to 1997
–
NCI NIH HHS CA45055NCI NIH HHS CA89041NCI NIH HHS R01 CA089041NICHD NIH HHS R01 HD38955
6 · The paper itself

Abstract

Attempts to delineate the mechanisms of estrogen action have promoted the creation of several estrogen receptor alpha (ERalpha) mouse models in the past decade. These traditional models are limited by the fact that the receptors are either absent or present throughout all stages of development. The purpose of this work was to develop a conditional transgenic model that would provide an in vivo method of controlling the spatial and temporal regulation of ERalpha expression. The tetracycline responsive system was utilized. Three lines of transgenic mice carrying a transgene composed of the coding sequence for murine ERalpha placed under the regulatory control of a tet operator promoter (tet-op) were generated. These three lines of tet-op-mERa mice were each mated to an established line of transgenic mice expressing a tetracycline-dependent transactivator protein (tTA) from the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). Double transgenic MMTV-tTA/tet-op-mERalpha mice were produced. All three lines demonstrated dominant gain of ERalpha shown by RT-PCR, immunoprecipitation, and immunohistochemistry. Transgene-specific ERalpha was expressed in numerous tissues including the mammary gland, salivary gland, testis, seminal vesicle, and epididymis. Expression was silenced by administration of doxycycline in the drinking water. This model can be utilized to evaluate the consequences of ERalpha dominant gain in targeted tissues at specific times during development. In this study dominant gain of ERalpha was associated with a reduction in epididymal/vas deferens and seminal vesicle weights consistent with the proposed action of ERalpha on fluid transport in the male reproductive tract. Combining this model with other dominant gain and gene knockout mouse models will be useful for testing effects of ERalpha action in combination with specific gene products and to evaluate if developmental and stage-specific expression of ERalpha can rescue identified phenotypes in gene knockout mice.

Indexed as

Mice, TransgenicAnimalsBase SequenceDNA, ComplementaryDNA PrimersEstrogen Receptor alphaFemaleGene Expression RegulationIn Vitro TechniquesMammary Tumor Virus, MouseMiceModels, AnimalOrgan SpecificityPolymerase Chain ReactionReceptors, EstrogenRepetitive Sequences, Nucleic AcidDNA, ComplementaryDNA PrimersEstrogen Receptor alphaReceptors, Estrogen

Identifiers

PMID12212839
OpenAlexW72372646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.